Literature DB >> 8349296

Association of Src-family kinase Lyn with B-cell antigen receptor.

T Yamamoto1, Y Yamanashi, K Toyoshima.   

Abstract

Antigen is thought to cross-link membrane-bound immunoglobulins (Igs) of B cells, causing proliferation and differentiation or the inhibition of growth. Compelling evidence suggests that protein-tyrosine phosphorylation is involved in signal transduction for cell proliferation and differentiation. Indeed cross-linking of membrane-bound IgM (mIgM) induced a rapid increase in tyrosine phosphorylation of at least 10 distinct proteins in B cells. The Src-family protein tyrosine kinase Lyn (p56lyn and p53lyn) is expressed preferentially in B cells. The Lyn protein and its kinase activity could be coimmunoprecipitated with both IgM and IgD from detergent lysates. Cross-linking of membrane-bound IgM with antibody induced down-regulation of the Lyn protein. From these data we concluded that Lyn is physically associated with mIgs. Further evidence showed that cross-linking of mIgM induced rapid increase in the kinase activity of Lyn and association of Lyn with 85-kDa noncatalytic subunit of phosphatidylinositol 3-kinase. Thus, Lyn is likely to participate in B-cell antigen receptor-mediated signaling. As a novel signaling molecule downstream of Lyn, we identified src homology 3-containing, transcription factor-like molecule p75HS1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349296     DOI: 10.1111/j.1600-065x.1993.tb00843.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  12 in total

1.  Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells.

Authors:  P A Tilbrook; E Ingley; J H Williams; M L Hibbs; S P Klinken
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

Review 2.  The B-cell receptor signaling pathway as a therapeutic target in CLL.

Authors:  Jennifer A Woyach; Amy J Johnson; John C Byrd
Journal:  Blood       Date:  2012-06-19       Impact factor: 22.113

Review 3.  Targeted therapy for chronic lymphocytic leukemia: current status and future directions.

Authors:  Jon E Arnason; Jennifer R Brown
Journal:  Drugs       Date:  2015-02       Impact factor: 9.546

Review 4.  The biology behind PI3K inhibition in chronic lymphocytic leukaemia.

Authors:  Valentín Ortiz-Maldonado; Marcial García-Morillo; Julio Delgado
Journal:  Ther Adv Hematol       Date:  2015-02

Review 5.  Targeting B Cell Signaling in Chronic Lymphocytic Leukemia.

Authors:  Jon E Arnason; Jennifer R Brown
Journal:  Curr Oncol Rep       Date:  2017-09       Impact factor: 5.075

Review 6.  Current Status of Bruton's Tyrosine Kinase Inhibitor Development and Use in B-Cell Malignancies.

Authors:  Andrew Aw; Jennifer R Brown
Journal:  Drugs Aging       Date:  2017-07       Impact factor: 3.923

7.  Host responses to live-attenuated Venezuelan equine encephalitis virus (TC-83): comparison of naïve, vaccine responder and nonresponder to TC-83 challenge in human peripheral blood mononuclear cells.

Authors:  Rebecca Erwin-Cohen; Aimee Porter; Phillip Pittman; Cynthia Rossi; Luis Dasilva
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

8.  Pathophysiological significance and therapeutic targeting of germinal center kinase in diffuse large B-cell lymphoma.

Authors:  Julie Marie Matthews; Shruti Bhatt; Matthew P Patricelli; Tyzoon K Nomanbhoy; Xiaoyu Jiang; Yasodha Natkunam; Andrew J Gentles; Ezequiel Martinez; Daxing Zhu; Jennifer Rose Chapman; Elena Cortizas; Ragini Shyam; Shideh Chinichian; Ranjana Advani; Li Tan; Jianming Zhang; Hwan Geun Choi; Robert Tibshirani; Sara J Buhrlage; Dita Gratzinger; Ramiro Verdun; Nathanael S Gray; Izidore S Lossos
Journal:  Blood       Date:  2016-05-05       Impact factor: 22.113

9.  Hematopoietic lineage cell-specific protein 1 immunoreactivity indicates an increased risk of poor overall survival in patients with ovarian carcinoma.

Authors:  Wenting Liu; Hiroaki Kajiyama; Kiyosumi Shibata; Yoshihiro Koya; Takeshi Senga; Fumitaka Kikkawa
Journal:  Oncol Lett       Date:  2018-04-13       Impact factor: 2.967

10.  Haematopoietic lineage cell-specific protein 1 (HS1) promotes actin-related protein (Arp) 2/3 complex-mediated actin polymerization.

Authors:  Takehito Uruno; Peijun Zhang; Jiali Liu; Jian-Jiang Hao; Xi Zhan
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.